I have seemingly discovered a formerly unknown interest of mine, if recent post history is any indication. This new obsession, in keeping with major recent efforts in the field of cancer research, is for better screening and early detection of cancer. It’s no secret, of course, that the earlier we diagnose cancer, the better chance a patient stands against the disease. This graph (from Wired) may help bring things into perspective.
Therefore, it should be no surprise that this story, published recently in the journal PNAS, caught my eye. Research at the Ohio State University Comprehensive Cancer Center, led by Dr. Carlo M. Croce, may lead to improved early detection of lung cancer by looking for biomarkers (traceable substances) in the blood called microRNAs.
Cancer, viruses and….more fluorescence. Yeah, oh my is right. Probably didn’t think a combination of cancer and viruses could be a good thing huh? This is the beauty of my line of work – this is one of those news pieces I found that just made me say, “Wow, that’s cool.” And really brilliant. But rather than continuing to bury the lead, let’s get right to business.
Researchers at Cincinnati Children’s Hospital Medical Center, led by Dr. Timothy P. Cripe have recently published work in which they created a genetically engineered herpes simplex virus designed to specifically target tumor cells and force them to secrete a signal into the blood to alert doctors to their presence. This work appears in the May 11 issue of PLoS One. Continue reading →